Sun Pharma to spotlight 14 dermatology studies at 2026 AAD annual meeting
The presentations underscore the company’s deep expertise in dermatology and immunology
The presentations underscore the company’s deep expertise in dermatology and immunology
As Tracky launches integrated health solution
Vapendavir is an oral, potent, broad-spectrum antiviral active against rhinoviruses and related respiratory enteroviruses
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
At the center of the collapse is opposition from the Federal Trade Commission
COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats
One task, one interaction, one pair, experts advocate
The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand
The Phase 1 dose-escalation trial enrolled 25 evaluable patients and was designed to determine the recommended dose of LYMPHIR
Subscribe To Our Newsletter & Stay Updated